Dmitry Nedosekin
Overview
Explore the profile of Dmitry Nedosekin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Ly S, Nedosekin D, Wong H
Am J Clin Dermatol
. 2023 Jan;
24(2):247-273.
PMID: 36630066
Biologic therapies targeting B-cells are emerging as an effective strategy to treat a variety of immune-mediated diseases. One of the most studied B-cell-targeted therapies is rituximab, an anti-CD20 monoclonal antibody...
3.
Jawad H, Yadem A, Menyaev Y, Sarimollaoglu M, Armstrong J, Watanabe F, et al.
Sci Rep
. 2022 May;
12(1):8671.
PMID: 35606373
In vivo, Cytophone has demonstrated the capability for the early diagnosis of cancer, infection, and cardiovascular disorders through photoacoustic detection of circulating disease markers directly in the bloodstream with an...
4.
Nedosekin D, Wilson K, Campbell K, Shalin S, Wong H
JAAD Case Rep
. 2021 Mar;
9:57-60.
PMID: 33665277
No abstract available.
5.
Nima Z, Vang K, Nedosekin D, Kannarpady G, Saini V, Bourdo S, et al.
Nanoscale
. 2019 Jan;
11(3):932-944.
PMID: 30608496
The use of graphene for biomedical and other applications involving humans is growing and shows practical promise. However, quantifying the graphitic nanomaterials that interact with cells and assessing any corresponding...
6.
Koonce N, Juratli M, Cai C, Sarimollaoglu M, Menyaev Y, Dent J, et al.
Biochem Biophys Res Commun
. 2017 Aug;
492(3):507-512.
PMID: 28822765
Noninvasive biological readouts of tumor metastatic risk and therapeutic efficacy are needed as healthcare costs rise. CTCs are the source of metastasis in distant organs that are responsible for the...
7.
Nima Z, Alwbari A, Dantuluri V, Hamzah R, Sra N, Motwani P, et al.
J Appl Toxicol
. 2017 Jul;
37(12):1370-1378.
PMID: 28730725
Multifunctional nanoparticles have high potential as targeting delivery vehicles for cancer chemotherapy. In this study, silver-decorated gold nanorods (AuNR\Ag) have been successfully used to deliver specific, targeted chemotherapy against breast...
8.
Vang K, Safina I, Darrigues E, Nedosekin D, Nima Z, Majeed W, et al.
Sci Rep
. 2017 Jul;
7(1):5513.
PMID: 28710434
Dendritic cells (DCs) can acquire, process, and present antigens to T-cells to induce an immune response. For this reason, targeting cancer antigens to DCs in order to cause an immune...
9.
Koonce N, Quick C, Hardee M, Jamshidi-Parsian A, Dent J, Paciotti G, et al.
Int J Radiat Oncol Biol Phys
. 2015 Oct;
93(3):588-96.
PMID: 26461001
Purpose: Although remarkable preclinical antitumor effects have been shown for tumor necrosis factor-α (TNF) alone and combined with radiation, its clinical use has been hindered by systemic dose-limiting toxicities. We...